IQVIA Holdings Inc. (IQV) stock
IQVNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 9/3013% above fair value
$245.82−4.73 (-1.89%)
Close on Nov 20, 2026Market cap $40.51BP/E 29.9Yield –
Iqvia free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Iqvia's free cash flow for the twelve months ending Sep 30, 2026 was $2.08B, down 6.0% year over year. For fiscal 2025 it was $2.05B, down 3.0% from the year before. Over ten years it grew 17.8% a year on average. The highest annual figure on record is $2.30B in fiscal 2021.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.05B | -3.0% |
| FY2024 | Dec 31, 2024 | $2.11B | +40.9% |
| FY2023 | Dec 31, 2023 | $1.50B | -5.4% |
| FY2022 | Dec 31, 2022 | $1.59B | -31.1% |
| FY2021 | Dec 31, 2021 | $2.30B | +71.4% |
| FY2020 | Dec 31, 2020 | $1.34B | +60.8% |
| FY2019 | Dec 31, 2019 | $835.00M | +5.0% |
| FY2018 | Dec 31, 2018 | $795.00M | +32.3% |
| FY2017 | Dec 31, 2017 | $601.00M | -13.6% |
| FY2016 | Dec 31, 2016 | $696.00M | +74.9% |
| FY2015 | Dec 31, 2015 | $398.00M | +13.7% |
| FY2014 | Dec 31, 2014 | $350.00M | +14.7% |
| FY2013 | Dec 31, 2013 | $305.02M | +15.4% |
| FY2012 | Dec 31, 2012 | $264.37M | +210.0% |
| FY2011 | Dec 31, 2011 | $85.27M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $667.00M | -13.6% |
| Q2 FY2026 | Jun 30, 2026 | $360.00M | +23.3% |
| Q1 FY2026 | Mar 31, 2026 | $491.00M | +15.3% |
| Q4 FY2025 | Dec 31, 2025 | $561.00M | -22.2% |
| Q3 FY2025 | Sep 30, 2025 | $772.00M | +35.2% |
| Q2 FY2025 | Jun 30, 2025 | $292.00M | -34.4% |
| Q1 FY2025 | Mar 31, 2025 | $426.00M | +13.0% |
| Q4 FY2024 | Dec 31, 2024 | $721.00M | +26.9% |
| Q3 FY2024 | Sep 30, 2024 | $571.00M | +30.7% |
| Q2 FY2024 | Jun 30, 2024 | $445.00M | +83.9% |
| Q1 FY2024 | Mar 31, 2024 | $377.00M | +49.0% |
| Q4 FY2023 | Dec 31, 2023 | $568.00M | +46.0% |
| Q3 FY2023 | Sep 30, 2023 | $437.00M | -37.4% |
| Q2 FY2023 | Jun 30, 2023 | $242.00M | +44.0% |
| Q1 FY2023 | Mar 31, 2023 | $253.00M | -23.6% |
| Q4 FY2022 | Dec 31, 2022 | $389.00M | -23.4% |
| Q3 FY2022 | Sep 30, 2022 | $698.00M | +2.3% |
| Q2 FY2022 | Jun 30, 2022 | $168.00M | -57.4% |
| Q1 FY2022 | Mar 31, 2022 | $331.00M | -53.9% |
| Q4 FY2021 | Dec 31, 2021 | $508.00M | -11.5% |
| Q3 FY2021 | Sep 30, 2021 | $682.00M | +63.5% |
| Q2 FY2021 | Jun 30, 2021 | $394.00M | +19.4% |
| Q1 FY2021 | Mar 31, 2021 | $718.00M | +3163.6% |
| Q4 FY2020 | Dec 31, 2020 | $574.00M | +28.7% |
| Q3 FY2020 | Sep 30, 2020 | $417.00M | +130.4% |
| Q2 FY2020 | Jun 30, 2020 | $330.00M | +39.8% |
| Q1 FY2020 | Mar 31, 2020 | $22.00M | – |
| Q4 FY2019 | Dec 31, 2019 | $446.00M | +59.9% |
| Q3 FY2019 | Sep 30, 2019 | $181.00M | -18.1% |
| Q2 FY2019 | Jun 30, 2019 | $236.00M | +17.4% |
| Q1 FY2019 | Mar 31, 2019 | -$28.00M | -129.8% |
| Q4 FY2018 | Dec 31, 2018 | $279.00M | +113.0% |
| Q3 FY2018 | Sep 30, 2018 | $221.00M | -36.3% |
| Q2 FY2018 | Jun 30, 2018 | $201.00M | +38.6% |
| Q1 FY2018 | Mar 31, 2018 | $94.00M | – |
| Q4 FY2017 | Dec 31, 2017 | $131.00M | -63.7% |
| Q3 FY2017 | Sep 30, 2017 | $347.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $145.00M | – |
| Q1 FY2017 | Mar 31, 2017 | -$22.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $361.00M | – |
See a number that looks wrong?